History of ADHD
Etiology and Epidemiology
Diagnosis
Treatment
Special populations
100

The term ADD first appeared in this edition of the DSM despite the symptoms being described in children for over 200 years

3rd 

100

This is the percent chance of a person with ADHD having a child with ADHD

50


100

These two sets of symptoms make up Criteria A and B

Inattention and Hyperactive-Impulsive

100

50% of persons with ADHD have sleep problems; This type of treatment is recommended for sleep problems in persons with ADHD 

Behavioral interventions


100

A brain injury can produce a syndrome known as this, which is treated the same as ADHD

Secondary ADHD

200

ADHD is classified as this type of disorder

Neurodevelopmental

200

Twin studies noted this percent of heritability of ADHD

76

200

This assessment tool kit includes the Weiss symptom record and Jerome Driving questionnaire

CADDRA

200

These are two non-pharmacological treatments that can be advocated for in post-secondary students

separate testing environment, extra time for testing, reduced homework, note taker

200

Due to the increase in sympathetic effects/adrenergic activity from psychostimulants, persons with this type of family cardiac history should get an EKG prior to starting a psychostimulant.

arrythmia or sudden cardiac death


EKG is not recommended as routine screening although should be done if if there are identifiable risk factors from the history or exam

you can also consider a cardiology consultation in these person

300

The 2nd edition of the DSM used this earlier term of ADHD

Hyperkinetic reaction of childhood

300

This landmark study of ADHD found that 70% of children with ADHD have at least 1 other psychiatric co-morbidity

MTA (Multimodal Treatment of ADHD)

300

These two medical diagnosis can often mimic ADHD in clinical practice

Sleep apnea and severe anemia

(also acceptable hearing or vision impairment, Thyroid dysfunction, hypoglycemia, lead poisoning, FASD, neurofibromatosis)

300

These medications are recommended for use in treating older adults with ADHD (assuming co-morbidities permit

First line agents

300

In persons with psychiatric comorbidity, this condition should be treated first.

The most impairing disorder

400

Amphetamines were given to children to alleviate this common problem and an unexpected behavioural effect was noticed in 'problem' children

Headache

400

Dysfunction of this pathway is thought to be the underlying mechanism of ADHD

Frontostriatal (dorsolateral and anterior cingulate)

400

This number of symptoms of each criterion must be present for a diagnosis of adult ADHD

5 of 9 (child is 6 of 9)

400

This psychological intervention is helpful for ADHD

Any of: cognitive behavioral approaches, parent training, social skills training

400

Persons with comorbid tourettes syndrome or tic disorder are often treated with these medications concurrently with a psychostimulant

atypical neuroleptics or alpha-2 agonists

500

In 1955, this medication became FDA approved for treatment of ADHD which was not a listed diagnosis at the time

Ritalin

500

This group of co-morbid disorders is most often co-morbid throughout the lifespan

Anxiety (also acceptable Learning disorders, tic/tourette's)

Childhood: anxiety, ODD, language

Teen: anxiety, tic moving into mood and SUD

Adult: Anxiety, depression, bipolar, SUD

500

This type of interview along with the Caddra toolkit, Direct Observation and Collateral History offer the best assessment for ADHD outside of complicated cases

Diagnostic

500

These 3 medications are second line treatments for ADHD

Atomoxetine, guanfacine XR, short acting psychostimulants

500

These must be weighed when treating a pregnant woman with psychostimulants

risks and benefits

treatment is not contraindicated, lack of treatment may cause increased risks, generally amphetamine stimulants are preferred over methylphenadate stimulants

M
e
n
u